| Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis M Simón-Talero, D Roccarina, J Martínez, K Lampichler, A Baiges, G Low, ... Gastroenterology 154 (6), 1694-1705. e4, 2018 | 207 | 2018 |
| Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study S Prieto-González, A García-Martínez, I Tavera-Bahillo, ... Medicine 94 (5), e486, 2015 | 109 | 2015 |
| Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis M Praktiknjo, M Simón-Talero, J Römer, D Roccarina, J Martínez, ... Journal of hepatology 72 (6), 1140-1150, 2020 | 99 | 2020 |
| Description and validation of histological patterns and proposal of a dynamic model of inflammatory infiltration in giant-cell arteritis J Hernandez-Rodriguez, G Murgia, I Villar, E Campo, SL Mackie, ... Medicine 95 (8), e2368, 2016 | 78 | 2016 |
| Biological treatments for SAPHO syndrome: an update D Firinu, G Murgia, M Maddalena Lorrai, M Pina Barca, M Monica Peralta, ... Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2014 | 55 | 2014 |
| Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated … S Prieto-González, N Terrades-García, M Corbera-Bellalta, ... RMD open 3 (2), e000570, 2017 | 45 | 2017 |
| Antiviral properties from plants of the Mediterranean flora G Sanna, P Farci, B Busonera, G Murgia, P La Colla, G Giliberti Natural Product Research 29 (22), 2065-2070, 2015 | 31 | 2015 |
| Prognostic significance of controlled attenuation parameter in patients with compensated advanced chronic liver disease C Margini, G Murgia, G Stirnimann, A De Gottardi, N Semmo, S Casu, ... Hepatology communications 2 (8), 933-944, 2018 | 26 | 2018 |
| Noninvasive markers of portal hypertension detect decompensation in overweight or obese patients with compensated advanced chronic liver disease Y Mendoza, S Cocciolillo, G Murgia, T Chen, C Margini, G Sebastiani, ... Clinical Gastroenterology and Hepatology 18 (13), 3017-3025. e6, 2020 | 22 | 2020 |
| Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease R Piccinni, SG Rodrigues, M Montani, G Murgia, MG Delgado, S Casu, ... Liver International 40 (5), 1151-1158, 2020 | 20 | 2020 |
| The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform M Sanna, D Firinu, PE Manconi, M Pisanu, G Murgia, V Piras, ... Molecular BioSystems 11 (6), 1552-1562, 2015 | 18 | 2015 |
| Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two‐dimensional shear wave elastography in non‐alcoholic fatty … YP Mendoza, SG Rodrigues, MG Delgado, G Murgia, NF Lange, ... Liver international 42 (1), 102-111, 2022 | 16 | 2022 |
| Potent and Selective Activity against Human Immunodeficiency Virus 1 (HIV-1) of Thymelaea hirsuta Extracts G Sanna, S Madeddu, G Murgia, G Serreli, M Begala, P Caboni, A Incani, ... Viruses 12 (6), 664, 2020 | 13 | 2020 |
| Biologics for ANCA-associated vasculitis G Murgia, D Firinu, P E Manconi, S R Del Giacco Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2014 | 6 | 2014 |
| Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency D Firinu, L Serusi, MM Lorrai, M Grande, G Murgia, MP Barca, F Collu, ... Amyloid 18 (sup1), 214-216, 2011 | 6 | 2011 |
| Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency D Firinu, L Serusi, MM Lorrai, M Grande, G Murgia, MP Barca, F Collu, ... Amyloid 18 (sup1), 214-216, 2011 | 6 | 2011 |
| Systemic lupus erythematosus occurring in a patient with Niemann–Pick type B disease G Murgia, D Firinu, R Meleddu, MM Lorrai, PE Manconi, SR Del Giacco Lupus 24 (12), 1332-1334, 2015 | 5 | 2015 |
| Simple non-invasive surrogates of portal hypertension predict clinical decompensation in overweight/obese patients with cACLD YP Mendoza Alcohol 7 (6.7), 8.0, 2019 | 2 | 2019 |
| Prognostic significance of controlled attenuation parameter in patients with compensated advanced chronic liver disease. Hepatol Commun. 2018 July 24; 2 (8): 929–40 C Margini, G Murgia, G Stirnimann, A De Gottardi, N Semmo, S Casu Liver International 63, 47, 2018 | 2 | 2018 |
| Controlled attenuation parameter reflects intrahepatic fat content in patients with compensated advanced chronic liver disease R Piccinni, S Rodrigues, M Montani, G Murgia, MG Delgado, S Casu, ... Journal of Hepatology 68, S638, 2018 | 1 | 2018 |
